Carbapenemase production refers to the ability of certain bacteria to produce enzymes that inactivate carbapenem antibiotics, leading to multidrug-resistant infections that are challenging to treat. This phenomenon is a significant concern in healthcare settings as it limits treatment options and necessitates the use of last-resort antibiotics.